Simplify Exchange Traded Funds (SURI)
Perusahaan Manajemen · ARCX · Seri S000078061 · Lihat di SEC EDGAR ↗
Data kepemilikan belum tersedia untuk dana ini.
Di halaman ini
- Arus dana Uang yang masuk dan keluar dari dana setiap bulan, dari pengajuan N-PORT.
- Kepemilikan Setiap posisi yang saat ini dipegang oleh dana, dengan bobotnya.
- Pemilik institusional Institusi 13F yang melaporkan kepemilikan ETF ini.
- Dana serupa Dana lain dengan kepemilikan yang tumpang tindih atau ukuran yang sebanding.
Aliran dana (dilaporkan SEC)
- Bulan lalu (Mar 2026)
- -$1.4M
- Kuartal berakhir Mar 2026
- -$756K
- 12 bulan terakhir
- -$467K
Apr 2025 – Mar 2026
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Komposisi Penuh 48 saham
| Nama | CUSIP | Nilai | % | Saldo | Kategori | Negara |
|---|---|---|---|---|---|---|
| United States Treasury Bills | 912797TE7 | $64.5M | 92,93 | 65.000.000 | DBT | US |
| Plains GP Holdings LP | 72651A207 | $30.9M | 44,55 | 1.272.360 | EC | US |
| Achieve Life Science Inc | 004468500 | $3.5M | 5,02 | 1.184.512 | EC | US |
| Phathom Pharmaceuticals Inc | 71722W107 | $2.9M | 4,20 | 262.386 | EC | US |
| Delcath Systems Inc. | 24661P807 | $2.4M | 3,49 | 261.126 | EC | US |
| Abeona Therapeutics Inc. | 00289Y206 | $2.2M | 3,23 | 500.342 | EC | US |
| Celldex Therapeutics Inc. | 15117B202 | $2.2M | 3,16 | 68.994 | EC | US |
| Milestone Pharmaceuticals Inc | 59935V107 | $1.8M | 2,58 | 1.506.405 | EC | CA |
| Oculis Holding AG | — | $1.8M | 2,56 | 66.667 | EC | CH |
| LeonaBio Inc. | 04746L203 | $1.5M | 2,21 | 149.279 | EC | US |
| Corcept Therapeutics Inc. | 218352102 | $1.5M | 2,19 | 37.763 | EC | US |
| Kyverna Therapeutics Inc | 501976104 | $1.5M | 2,15 | 173.106 | EC | US |
| Inventiva SA | 46124U107 | $1.3M | 1,82 | 227.923 | EC | FR |
| Viridian Therapeutics Inc | 92790C104 | $1.1M | 1,59 | 56.231 | EC | US |
| Aquestive Therapeutics Inc | 03843E104 | $972K | 1,40 | 234.279 | EC | US |
| VOR BIOPHARMA INC | 929033207 | $955K | 1,38 | 53.510 | EC | US |
| Orchestra BioMed Holdings Inc | 68572M106 | $932K | 1,34 | 219.387 | EC | US |
| Zevra Therapeutics Inc | 488445206 | $897K | 1,29 | 96.246 | EC | US |
| Compass Pathways plc | 20451W101 | $880K | 1,27 | 159.052 | EC | GB |
| Telesat Canada /Telesat LLC | 87952VAR7 | $800K | 1,15 | 1.000.000 | DBT | CA |
| Trevi Therapeutics Inc | 89532M101 | $780K | 1,13 | 65.412 | EC | US |
| Ocular Therapeutix Inc | 67576A100 | $762K | 1,10 | 90.000 | EC | US |
| Sab Biotherapeutics Inc | 78397T202 | $717K | 1,03 | 187.230 | EC | US |
| Upstream Bio Inc | 91678A107 | $700K | 1,01 | 77.793 | EC | US |
| Eyepoint Inc. | 30233G209 | $690K | 0,99 | 53.526 | EC | US |
| 4D Molecular Therapeutics Inc | 35104E100 | $656K | 0,95 | 70.430 | EC | US |
| Palisade Bio Inc | 696389402 | $612K | 0,88 | 350.000 | EC | US |
| Zealand Pharma As | — | $569K | 0,82 | 12.330 | EC | DK |
| KALARIS THERAPEUTICS INC | 482929106 | $504K | 0,73 | 87.426 | EC | US |
| Immunic Inc. | 4525EP101 | $487K | 0,70 | 438.932 | EC | US |
| Coherus Oncology Inc. | 19249H103 | $428K | 0,62 | 253.140 | EC | US |
| Akero Therapeutics Inc | 009CVR044 | $427K | 0,62 | 145.609 | EC | US |
| Corvus Pharmaceuticals Inc | 221015100 | $296K | 0,43 | 20.242 | EC | US |
| Ovid Therapeutics Inc | 690469101 | $290K | 0,42 | 130.813 | EC | US |
| ARTIVA BIOTHERAPEUTICS INC | 04317A107 | $150K | 0,22 | 23.230 | EC | US |
| CONNECT BIOPHARMA HOLDINGS LTD | — | $140K | 0,20 | 53.375 | EC | KY |
| Chinook Therapeutics Inc | 169CVR016 | $2K | 0,00 | 25.000 | EC | US |
| Eiger BioPharmaceuticals Inc | 28249U204 | $900 | 0,00 | 90.000 | EC | US |
| MILESTONE PHARMACE WTS | — | $2 | 0,00 | 1.842.974 | EC | US |
| MILESTONE PHARMACE WTS | — | $2 | 0,00 | 1.842.974 | EC | US |
| Achieve Life Science Inc | 004468187 | $1 | 0,00 | 966.667 | EC | US |
| JASPER THERAPEUTIC WTS | — | $1 | 0,00 | 609.053 | EC | US |
| WTS - TENAYA THERAPEUTICS | — | $1 | 0,00 | 560.000 | EC | US |
| QUOIN PHARMACEUTIC WTS | — | $0 | 0,00 | 34.895 | EC | US |
| QUOIN PHARMACEUTIC WTS | — | $0 | 0,00 | 34.895 | EC | US |
| QUOIN PHARMACEUTIC WTS | — | $0 | 0,00 | 34.895 | EC | US |
| QUOIN PHARMACEUTIC WTS | — | $0 | 0,00 | 34.895 | EC | US |
| MORGAN STANLEY & CO. LLC | — | -$63.2M | -91,06 | -63.152.370 | RA | US |
Pemilik institusional (13F) 1 pengaju
Institusi yang melaporkan kepemilikan ETF ini dalam Formulir SEC 13F triwulanan mereka. Hanya posisi long; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
| Institusi | Nilai | % dari 13F yang dilacak | Saham | Tipe | Per tanggal |
|---|---|---|---|---|---|
| JANE STREET GROUP, LLC | $221.164 | 100,00% | 12.359 | Saham | 30 Juni 2026 |
Dana sejawat
Serupa berdasarkan ukuran
| Dana | AUM |
|---|---|
| GTR WisdomTree Trust | $69.5M |
| FINT Advisors' Inner Circle Fund II | $69.6M |
| BNDS Series Portfolios Trust | $69.7M |
| PQDI Principal Exchange-Traded Funds | $70.0M |
| OCTU AIM ETF Products Trust | $70.1M |
| EASG DBX ETF Trust | $69.1M |
| GAA Cambria ETF Trust | $68.9M |
| AVMA AMERICAN CENTURY ETF TRUST | $68.8M |
| LABD Direxion Shares ETF Trust | $68.1M |
| QCOC First Trust Exchange-Traded Fun… | $68.0M |